Your browser doesn't support javascript.
loading
Peginterferon alfa-2a for AIDS-associated Kaposi sarcoma: experience with 10 patients.
Rokx, Casper; van der Ende, Marchina E; Verbon, Annelies; Rijnders, Bart J A.
Afiliación
  • Rokx C; Department of Internal Medicine, Section on Infectiology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Clin Infect Dis ; 57(10): 1497-9, 2013 Nov.
Article en En | MEDLINE | ID: mdl-23912848
ABSTRACT
In this observational cohort study, 10 patients with extensive or treatment-refractory AIDS-associated Kaposi sarcoma were treated with peginterferon alfa-2a. Tumor responses were observed in 9 patients with a median progression-free survival of 645 days. Peginterferon alfa-2a could be an effective therapy for extensive or treatment-resistant Kaposi sarcoma.
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Polietilenglicoles / Sarcoma de Kaposi / Interferón-alfa / Infecciones Oportunistas Relacionadas con el SIDA Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2013 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Polietilenglicoles / Sarcoma de Kaposi / Interferón-alfa / Infecciones Oportunistas Relacionadas con el SIDA Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2013 Tipo del documento: Article